AMREP Corporation Reports 32% Increase in Total Revenues for Fiscal Year Ending April 30, 2025

Reuters
2025/07/26
AMREP Corporation Reports 32% Increase in Total Revenues for Fiscal Year Ending April 30, 2025

AMREP Corporation has released its annual report for the fiscal year ending April 30, 2025. The company, primarily engaged in land development and homebuilding, reported a reduction in revenues from the sale of developed residential land during the fiscal year ending April 30, 2026, compared to 2024 and 2025. This anticipated decline is attributed to reduced active land development projects and delays in proceeding with new projects due to market headwinds, uncertainty, and infrastructure delays. The company highlighted several factors contributing to the uncertain economic conditions affecting demand for land and homes, including changes in mortgage interest rates, inflation, tariffs, and labor shortages. Despite these challenges, AMREP Corporation expects some revenue from its backlog of homes under contract and in production, with expected sale revenues materializing when such homes are closed. The company is also cautious about future economic conditions impacting its operations and has adjusted its outlook accordingly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMREP Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001410578-25-001515), on July 25, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10